In the last trading session, 0.15 million shares of the Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) were traded, and its beta was 0.29. Most recently the company’s share price was $1.45, and it changed around -$0.01 or -0.68% from the last close, which brings the market valuation of the company to $32.29M. CYCC currently trades at a discount to its 52-week high of $49.34, offering almost -3302.76% off that amount. The share price’s 52-week low was $1.43, which indicates that the current value has risen by an impressive 1.38% since then.

Cyclacel Pharmaceuticals Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended CYCC as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) trade information

Instantly CYCC has showed a red trend with a performance of -0.68% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 2.1500 on recent trading dayincreased the stock’s daily price by 32.56%. The company’s shares are currently down -75.90% year-to-date, but still down -27.50% over the last five days. On the other hand, Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) is -60.43% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $1, which translates to bulls needing to decrease their stock price by -45.0% from its current value. Analyst projections state that CYCC is forecast to be at a low of $1 and a high of $1.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 57.31%.

CYCC Dividends

Cyclacel Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in June. The annual dividend yield of the stock is 165.52 percent and its annual dividend per share was 2.40. It is important to note, however, that the 165.52% dividend yield ratio should be regarded as a guide only, as many other factors should be taken into consideration before making any investment decision.

Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 3.24 shares worth $4696.0, making up 0.01% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held roughly 653.0 shares worth around $946.0, which represents about 0.00% of the total shares outstanding.